@prefix c0x: <http://data.loterre.fr/ark:/67375/C0X> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc11: <http://purl.org/dc/elements/1.1/> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

c0x:-ZZSTX1BQ-P
  skos:inScheme c0x: ;
  skos:note "Virus SARS-CoV-2 inactivé"@fr ;
  skos:definition "BBIBP-CorV is one of two inactivated virus COVID-19 vaccines being developed by Sinopharm. As of December 2020, it is in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. By November, nearly one million people had taken the vaccine through China's emergency use program. (Wikipédia)"@en ;
  skos:related c0x:-C3KV4VWN-7, c0x:-JRP4LKS6-9 ;
  skos:exactMatch <https://en.wikipedia.org/wiki/BBIBP-CorV> ;
  dc11:creator "Patricia Fener" ;
  skos:broader c0x:-WZZNXPM8-T ;
  dc:modified "2020-12-22"^^xsd:date ;
  skos:prefLabel "BBIBP-CorV"@en, "BBIBP-CorV"@fr ;
  a skos:Concept ;
  dc:created "2020-12-16"^^xsd:date .

c0x:-WZZNXPM8-T
  skos:prefLabel "inactivated vaccine"@en, "vaccin inerte"@fr ;
  a skos:Concept ;
  skos:narrower c0x:-ZZSTX1BQ-P .

c0x:-C3KV4VWN-7
  skos:prefLabel "inactivated SARS-CoV-2 virus"@en, "virus SARS-CoV-2 inactivé"@fr ;
  a skos:Concept ;
  skos:related c0x:-ZZSTX1BQ-P .

c0x: a skos:ConceptScheme .
c0x:-JRP4LKS6-9
  skos:prefLabel "Beijing Bio-Institute Biological Products"@en, "Institut de produits biologiques de Pékin"@fr ;
  a skos:Concept ;
  skos:related c0x:-ZZSTX1BQ-P .